InsidersTradesSigma
Track the GENEREX BIOTECHNOLOGY CORP stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). The latest transaction was disclosed on 16 February 2016 (Levée d'options). Among the most active insiders: Brusegard David. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
GENEREX BIOTECHNOLOGY CORP is a company focused on developing therapeutic solutions for the treatment of diabetes and other diseases. It is listed on NASDAQ under the symbol XNAS.